Home > Journals > The Journal of Sports Medicine and Physical Fitness > Past Issues > Articles online first > The Journal of Sports Medicine and Physical Fitness 2021 Jul 13

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

The Journal of Sports Medicine and Physical Fitness 2021 Jul 13

DOI: 10.23736/S0022-4707.21.12764-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?

Domenico FILOMENA 1, 2, Lucia I. BIRTOLO 1, 2, Marco PENZA 2, 3, Gianfranco GUALDI 2, Barbara DI GIACINTO 2, Viviana MAESTRINI 1, 2

1 Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy; 2 Institute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Rome, Italy; 3 Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy


PDF


Recent reports based on Cardiovascular Magnetic Resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening protocol after COVID-19 has been questioned. Current evidence does not seem to support the routine use of CMR and the prescription of CMR should be based upon clinical indication.


KEY WORDS: COVID-19; Athletes; CMR

top of page